Antitumor necrosis factor alpha monoclonal antibody inhibits colorectal cancer growth in orthotopic transplant mouse model

被引:0
|
作者
Takasago, Takeshi [1 ]
Hayashi, Ryohei [1 ]
Ueno, Yoshitaka [1 ]
Ariyoshi, Misa [2 ]
Yamashita, Ken [1 ]
Hiyama, Yuichi [3 ]
Takigawa, Hidehiko [1 ]
Yuge, Ryo [1 ]
Urabe, Yuji [4 ]
Kitadai, Yasuhiko [5 ]
Oka, Shiro [2 ]
Tanaka, Shinji [1 ]
机构
[1] Hiroshima Univ Hosp, IBD Ctr, Hiroshima, Japan
[2] Hiroshima Univ Hosp, Dept Gastroenterol & Metab, Hiroshima, Japan
[3] Hiroshima Univ Hosp, Dept Clin Res Ctr, Hiroshima, Japan
[4] Hiroshima Univ Hosp, Dept Gastrointestinal Endoscopy & Med, Hiroshima, Japan
[5] Prefectural Univ Hiroshima, Dept Hlth & Sci, Hiroshima, Japan
关键词
antitumor necrosis factor alpha monoclonal antibody; colorectal; cancer; orthotopic transplant mouse model; tumor microenvironment;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
0355
引用
收藏
页码:74 / 74
页数:1
相关论文
共 50 条
  • [31] Establishment of a novel mouse model of colorectal cancer by orthotopic transplantation
    Chen, Cewen
    Fu, Qiaochu
    Wang, Lei
    Tanaka, Shinya
    Imajo, Masamichi
    BMC CANCER, 2025, 25 (01)
  • [32] An Optimal Orthotopic Mouse Model for Human Colorectal Cancer Primary Tumor Growth and Spontaneous Metastasis
    Hite, Nathan
    Klinger, Aaron
    Hellmers, Linh
    Maresh, Grace A.
    Miller, Peter E.
    Zhang, Xin
    Li, Li
    Margolin, David A.
    DISEASES OF THE COLON & RECTUM, 2018, 61 (06) : 698 - 705
  • [33] Vascular endothelial growth factor monoclonal antibody inhibits growth of anaplastic thyroid cancer xenografts in nude mice
    Bauer, AJ
    Terrell, R
    Doniparthi, NK
    Patel, A
    Tuttle, RM
    Saji, M
    Ringel, MD
    Francis, GL
    THYROID, 2002, 12 (11) : 953 - 961
  • [34] Infliximab chimeric antitumor necrosis factor-α monoclonal antibody as potential treatment for myelodysplastic syndromes
    Stasi, R
    Amadori, S
    Newland, AC
    Provan, D
    LEUKEMIA & LYMPHOMA, 2005, 46 (04) : 509 - 516
  • [35] MONOCLONAL ANTITUMOR NECROSIS FACTOR-ALPHA ANTIBODY SUPPRESSES REJECTION, BUT ENHANCES INFECTIOUS COMPLICATIONS IN RAT-LIVER ALLOGRAFT RECIPIENTS
    SHIRAISHI, M
    SHAKED, A
    YASUNAGA, C
    HASUIKE, Y
    IMAGAWA, DK
    BUSUTTIL, RW
    TRANSPLANTATION PROCEEDINGS, 1993, 25 (01) : 128 - 129
  • [36] A function-blocking monoclonal antibody directed against the collagen-binding α2 integrin subunit inhibits primary tumor growth and metastasis in a fluorescent orthotopic mouse model of pancreatic cancer
    Grzesiak, John J.
    Cao, Hop S. Tran
    Kaushal, Sharmeela
    Hoffman, Robert M.
    Bouvet, Michael
    CANCER RESEARCH, 2011, 71
  • [37] A neutralizing human monoclonal antibody to Platelet-derived growth factor receptor alpha inhibits the growth of tumor xenografts.
    Loizos, N
    Xu, Y
    Huber, J
    Liu, M
    Lu, D
    Finnerty, B
    Hooper, A
    Apblett, R
    Malikzay, A
    Bassi, R
    Prewett, M
    Jimenez, X
    Tonra, J
    Wu, Y
    Pereira, D
    Zhu, Z
    Ludwig, D
    Hicklin, D
    Bohlen, P
    Witte, L
    Kussie, P
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6190S - 6190S
  • [38] The A12 antibody to the insulin-like growth factor receptor-1 inhibits the growth of anaplastic thyroid carcinoma in an orthotopic nude mouse model.
    Wang, ZY
    Kim, S
    Yazici, YD
    Younes, MN
    Jasser, SA
    Bucana, CD
    El-Naggar, AK
    Weber, RS
    Myers, JN
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9043S - 9043S
  • [39] INHIBITION OF THE RELEASE OF SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTORS IN EXPERIMENTAL ENDOTOXEMIA BY AN ANTITUMOR NECROSIS FACTOR-ALPHA ANTIBODY
    JANSEN, J
    VANDERPOLL, T
    LEVI, M
    TENCATE, H
    GALLATI, H
    TENCATE, JW
    VANDEVENTER, SJH
    JOURNAL OF CLINICAL IMMUNOLOGY, 1995, 15 (01) : 45 - 50
  • [40] ZD6126 inhibits orthotopic growth and peritoneal carcinomatosis in a mouse model of human gastric cancer
    McCarty, MF
    Takeda, A
    Stoeltzing, O
    Liu, W
    Fan, F
    Reinmuth, N
    Akagi, M
    Bucana, C
    Mansfield, PF
    Ryan, A
    Ellis, LM
    BRITISH JOURNAL OF CANCER, 2004, 90 (03) : 705 - 711